Готові списки джерел за темами / Screening of Breast Cancer

Добірка наукової літератури з теми "Screening of Breast Cancer"

Автор: Grafiati
Опубліковано: 6 вересня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Screening of Breast Cancer".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Screening of Breast Cancer"

1

Yamauchi, Hideko. "Breast Cancer Screening System in USA." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 115–26. http://dx.doi.org/10.3804/jjabcs.21.115.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Arima, Yuriko. "Breast Cancer Screening Programme in the UK." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 127–37. http://dx.doi.org/10.3804/jjabcs.21.127.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chou, Yi-Hong. "Evolution of Breast Cancer Screening in Taiwan." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 138–42. http://dx.doi.org/10.3804/jjabcs.21.138.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Gordon, Paula B. "The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening." Current Oncology 29, no. 5 (May 17, 2022): 3595–636. http://dx.doi.org/10.3390/curroncol29050291.

Повний текст джерела
Анотація:
The purpose of breast cancer screening is to find cancers early to reduce mortality and to allow successful treatment with less aggressive therapy. Mammography is the gold standard for breast cancer screening. Its efficacy in reducing mortality from breast cancer was proven in randomized controlled trials (RCTs) conducted from the early 1960s to the mid 1990s. Panels that recommend breast cancer screening guidelines have traditionally relied on the old RCTs, which did not include considerations of breast density, race/ethnicity, current hormone therapy, and other risk factors. Women do not all benefit equally from mammography. Mortality reduction is significantly lower in women with dense breasts because normal dense tissue can mask cancers on mammograms. Moreover, women with dense breasts are known to be at increased risk. To provide equity, breast cancer screening guidelines should be created with the goal of maximizing mortality reduction and allowing less aggressive therapy, which may include decreasing the interval between screening mammograms and recommending consideration of supplemental screening for women with dense breasts. This review will address the issue of dense breasts and the impact on the stage of breast cancer at the time of diagnosis, and discuss options for supplemental screening.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Schouten, L. J., J. Th Schlangen, J. M. de Rijke, and A. L. M. Verbeek. "Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands." Journal of Medical Screening 5, no. 1 (March 1, 1998): 37–41. http://dx.doi.org/10.1136/jms.5.1.37.

Повний текст джерела
Анотація:
Objective To evaluate the effect of a breast cancer screening programme by record linkage with the cancer registry. Setting Breast cancer screening programme in mid- and southern Limburg, the Netherlands. Method The data files of the breast cancer screening programme and the Maastricht Cancer Registry were linked in order to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. Results From 1990 until 1995 90 001 women participated in the first round of the breast cancer screening programme and 64 637 in subsequent rounds. After the introduction of screening the annual number of breast cancer diagnoses increased by almost 50%. The incidence decreased to previous levels after completion of the first screening round. Record linkage detected 219 interval cancers (within two and a half years of a screening), a proportionate incidence of 31% in the first year and 60% in the second year of the two-year interval between screenings. The incidence of node positive breast cancer was 1% lower in 1994 and 15% lower in 1995 than the incidence in the period 1987–90. Conclusions Evaluation of the effect of breast cancer screening in the Netherlands can be performed using routinely available cancer registry data. The results of this evaluation seem promising, but further studies are necessary to find ways to reduce the incidence of interval cancer.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Calinescu, Gina, Corina Grigoriu, Athir Eddan, Nicolae Bacalbasa, Irina Balescu, Bianca-Margareta Mihai, Roxana Elena Bohiltea, and Claudia Stoica. "Breast density and breast cancer." Romanian Journal of Medical Practice 16, S7 (December 30, 2021): 29–32. http://dx.doi.org/10.37897/rjmp.2021.s7.9.

Повний текст джерела
Анотація:
Breast density is increasingly recognized as an independent risk factor for the development of breast cancer. It has been shown to be associated with a four-to sixfold increase a woman's risk of malignant breast disease. Increased breast density, as identified on mammography, is known to decrease the diagnostic sensitivity of the examination, which is of great concern to women at increased risk for breast cancer. Dense tissue has generally been associated with younger age and premenopausal status, with the assumption that breast density gradually decreases after menopause. However, the actual proportion of older women with dense breasts is unknown. Unfortunately, mammography is less accurate on dense breast tissue compared to fattier breast tissue. Multiple studies suggest a solution to this by demonstrating the ability of supplemental screening ultrasound to detect additional malignant lesions in women with dense breast tissue but with negative mammography. Improved screening methods for women with dense breasts are needed due to their increased risk of breast cancer and of failed early diagnosis by screening mammography.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ding, Rui, Yi Xiao, Miao Mo, Ying Zheng, Yi-Zhou Jiang, and Zhi-Ming Shao. "Breast cancer screening and early diagnosis in Chinese women." Cancer Biology & Medicine 19, no. 4 (April 5, 2022): 450–67. http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0676.

Повний текст джерела
Анотація:
Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of screening with a combination of ultrasound and mammography is stressed. Moreover, Chinese patients with breast cancers have several ancestry-specific genetic features, and aiding in the determination of genetic screening strategies for identifying high-risk populations. On the basis of current studies, we summarize the development of risk-stratified breast cancer screening guidelines for Chinese women and describe the significant improvement in the prognosis of patients with breast cancer in China.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

P., Priyadarshini,, Sarathi, S., and Hemavathy, V. "Breast Cancer Screening." CARDIOMETRY, no. 24 (November 30, 2022): 1000–1005. http://dx.doi.org/10.18137/cardiometry.2022.24.10001005.

Повний текст джерела
Анотація:
Breast cancer is the most frequent cancer in women, impacting one out of every eight women at some point in their lives. Despite the fact that it is more frequent in older women, breast cancer seldom strikes women under the age of 45. Women under the age of 45 account for around 9% of all new cases of breast cancer in the United States. The most important methods for preventing breast cancer deaths are early detection and cutting-edge cancer treatment. Breast cancer that is detected early, when it is little and hasn’t spread, is easier to treat. The most accurate method for identifying breast cancer early is through frequent screening examinations. According to the American Cancer Society, screening is recommended for both women who are at medium risk of breast cancer and those who are at high risk. Breast cancer screening tests are used to detect the disease before symptoms such as a palpable lump appear. Screening tests and exams are used to identify illness in persons who do not exhibit symptoms. Clinical and self-breast examinations, mammography, genetic screening, ultrasound, and magnetic resonance imaging have all been used as screening treatments.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Bukhari, Hassan, Asim Shaukat, and Nosheen Ahmad. "BREAST CANCER SCREENING;." Professional Medical Journal 24, no. 01 (January 18, 2017): 42–46. http://dx.doi.org/10.29309/tpmj/2017.24.01.400.

Повний текст джерела
Анотація:
Objectives: To compare the efficacy of Magnetic resonance imaging andMammography for Breast-Cancer Screening in high risk Women with a Familial or GeneticPredisposition. Study Design: Cross-sectional study. Setting: Department of Radiology AlliedHospital, Faisalabad. Duration: From January 2012 to December 2014, Sample size: 299.Methods: A total of 299 females at high risk of breast cancer were included in this study andthey underwent screening rounds of Mammogram and contrast enhanced dynamic breastMRI once a year with independent readings. Both the imaging modalities were interpreted byexperience radiologist and all the images were categorized using Breast Imaging Reportingand Data System. In each patient, histopathology results were considered the standard criteriafor the calculation of the sensitivity, specificity for both Mammogram and Breast MRI lesions.Results: Mean age of the patients was 46.69±11.86 years. Mammography revealed 11 (3.68%)true positive breast lesions, 22 (7.36%) false positive lesion, 247 (82.61%) true negative and19 (6.35%) false negative lesions yielding the sensitivity of 36.67% and diagnostic accuracy of86.3%. Dynamic breast MRI revealed 28 (9.36%) true positive breast lesions with 5 (1.67%) falsepositive, 264 (88.29%) true negative and 2 (0.67%) false negative lesions yielding sensitivity of93.3%,specificity of 98.14%,PPV=84.85%,NPV=99.25% and diagnostic accuracy of 97.66%.MRI breast was significantly more sensitive (93.3 vs. 36.67%) and accurate (97.66 vs. 86.3%)than mammography. Conclusion: MRI is more sensitive than mammography in detectingtumors in women with an inherited susceptibility to breast cancer.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Lynge, Elsebeth, Ilse Vejborg, Zorana Andersen, My von Euler-Chelpin, and George Napolitano. "Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening." Journal of Clinical Medicine 8, no. 11 (November 19, 2019): 2021. http://dx.doi.org/10.3390/jcm8112021.

Повний текст джерела
Анотація:
Background: Attention in the 2000s on the importance of mammographic density led us to study screening sensitivity, breast cancer incidence, and associations with risk factors by mammographic density in Danish breast cancer screening programs. Here, we summarise our approaches and findings. Methods: Dichotomized density codes: fatty, equal to BI-RADS density code 1 and part of 2, and other mixed/dense data from the 1990s—were available from two counties, and BI-RADS density codes from one region were available from 2012/13. Density data were linked with data on vital status, incident breast cancer, and potential risk factors. We calculated screening sensitivity by combining data on screen-detected and interval cancers. We used cohorts to study high density as a predictor of breast cancer risk; cross-sectional data to study the association between life style factors and density, adjusting for age and body mass index (BMI); and time trends to study the prevalence of high density across birth cohorts. Results: Sensitivity decreased with increasing density from 78% in women with BI-RADS 1 to 47% in those with BI-RADS 4. For women with mixed/dense compared with those with fatty breasts, the rate ratio of incident breast cancer was 2.45 (95% CI 2.14–2.81). The percentage of women with mixed/dense breasts decreased with age, but at a higher rate the later the women were born. Among users of postmenopausal hormone therapy, the percentage of women with mixed/dense breasts was higher than in non-users, but the patterns across birth cohorts were similar. The occurrence of mixed/dense breast at screening age decreased by a z-score unit of BMI at age 13—odds ratio (OR) 0.56 (95% CI 0.53–0.58)—and so did breast cancer risk and hazard ratio (HR) 0.92 (95% CI 0.84–1.00), but it changed to HR 1.01 (95% CI 0.93–1.11) when controlled for density. Age and BMI adjusted associations between life style factors and density were largely close to unity; physical activity OR 1.06 (95% CI 0.93–1.21); alcohol consumption OR 1.01 (95% CI 0.81–1.27); air pollution OR 0.96 (95% 0.93–1.01) per 20 μg/m3; and traffic noise OR 0.94 (95% CI 0.86–1.03) per 10 dB. Weak negative associations were seen for diabetes OR 0.61 (95% CI 0.40–0.92) and cigarette smoking OR 0.86 (95% CI 0.75–0.99), and a positive association was found with hormone therapy OR 1.24 (95% 1.14–1.35). Conclusion: Our data indicate that breast tissue in middle-aged women is highly dependent on childhood body constitution while adult life-style plays a modest role, underlying the need for a long-term perspective in primary prevention of breast cancer.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Screening of Breast Cancer"

1

Hann, A. P. "The politics of breast cancer screening." Thesis, University of East Anglia, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309962.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Chen, Hsiu-Hsi. "Mathematical models for progression of breast cancer and evaluation of breast cancer screening." Thesis, University of Cambridge, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388263.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Song, Ningning. "Quantitative photoacoustic tomography for breast cancer screening." Thesis, Ecole centrale de Marseille, 2014. http://www.theses.fr/2014ECDM0005/document.

Повний текст джерела
Анотація:
Ces travaux de thèse sont motivés par le développement de techniques d’imagerie alternatives pour le diagnostic précoce du cancer du sein. Parmi celles-ci, l’imagerie photoacoustique couple potentiellement les avantages de deux modalités d’imagerie non-invasives, à savoir la quantification de contrastes physiologiques du fait de l’excitation optique et la haute résolution du fait d’un sondage acoustique.Le but de ces travaux est de proposer une modélisation multiondes du phénomène photoacoustique, et d’incorporer ce modèle dans un algorithme de reconstruction efficace pour résoudre le problème inverse. Celui-ci se rapporte à la reconstruction de cartes de propriétés physiques (optique et/ou acoustiques) de l’intérieur du sein. La Méthode des Eléments Finis (MEF) a été retenue pour résoudre l’équation de propagation optique. Pour la résolution de l’équation de propagation acoustique, une méthode semi-analytique, basée sur des calculs par transformées de Fourier (méthod k-space), a été choisie. Pour la résolution du problème inverse, deux approches ont été étudiées : i) un sondage passif, permettant de remonter à la distribution de pression initiale, à l’aide de la méthode de retournement temporel ; ii) un sondage actif, où l’on interroge le milieu sélectivement sous différentes excitations, permettant de remonter quantitativement aux propriétés optiques du milieu. On appelle cette dernière approche Tomographie PhotoAcoustique Quantitative (TPAQ). Une étude spécifique sur le protocole d’illumination/détection a été conduite, prenant également en compte les contraintes expérimentales
The present work was motivated by the development of alternative imaging techniques for breast cancer early diagnosis, that is photoacoustic imaging, which potentially couples the merits of optical imaging and ultrasound imaging, that is high optical functional contrasts brought by optical probing and high spatial resolution by ultrasound detection. Our work aims at modeling the photoacoustic multiwave phenomenon and incorporate it in an efficient reconstruction algorithm to solve the inverse problem. The inverse problem consists in the recovery of interior maps of physical properties of the breast. The forward model couples optical and acoustic propagations. The Finite Element Method (FEM) was chosen for solving the optical propagation equation, while a semi-analytical method based on Fourier transforms calculations (k-space method) was preferred for solving the acoustic propagation equation. For the inverse model, time reversal method was adopted to reconstruct the initial pressure distribution, an active approach of the inverse problem was also achieved, which decoupled the optical properties from measured photoacoustic pressure, this approach is called quantitative photoacoustic tomography (QPAT), in this approach, illumination/detection protocol was studied, and the experimental set up is also take into consideration. In the last step, photoacoustic pressure measurements obtained from experiment and simulation are studied and compared
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Chang, Sue-Ling. "Breast cancer subtypes and screening mammography sensitivity." Thesis, Université Laval, 2014. http://www.theses.ulaval.ca/2014/30680/30680.pdf.

Повний текст джерела
Анотація:
Les cancers du sein peuvent être classifiés selon le statut de récepteur d’estrogène (RE), de récepteur de progestérone (RP), de récepteur HER2, ou selon quatre sous-types (Luminal A, Luminal B, HER2-enrichi, Triple-négatif) ayant des propriétés biologiques et cliniques différentes. La sensibilité du dépistage par mammographie pourrait varier selon ces types de cancers mais ceci n’est pas encore clair. L’agressivité de la tumeur, mesurée par le grade histologique pourrait expliquer cette association. Les types de cancers d’intervalle ont été comparés à ceux de cancers détectés par dépistage parmi 1536 cas infiltrants provenant d’un centre de référence de Québec. Les tumeurs RE-négatif, RP-négatif, HER2-positif, Luminal B, HER2-enrichi et TPN étaient tous plus fréquentes chez les femmes avec cancers d’intervalle que chez celles avec cancers détectés par dépistage. À l’exception des tumeurs HER2-positif et HER2-enrichi, le grade histologique expliquait en grande partie la variabilité observée entre les types de cancer et la sensibilité.
Breast cancers can be classified according to tumour estrogen (ER) and progesterone (PR) receptors, human epidermal growth factor receptor 2 (HER2), and according to four subtypes (Luminal A, Luminal B, HER2-enriched, Triple-negative), each with different biological and clinical profiles. These tumour types may also influence screening mammography sensitivity but this is still not clear. Tumour aggressiveness, measured by the histological grade, may also play a role in explaining this association. Interval cancer types were compared to screen-detected cancer types in 1536 invasive cases obtained from a reference center in Quebec. ER-negative, PR-negative and HER2-positive, Luminal B, HER2-enriched and TPN tumours were all more frequent in women with interval cancers than in women with screen-detected cancers. Except for HER2-positive and HER2-enriched tumours, histological grade explained most of the variability observed between tumour receptor status, subtypes and sensitivity.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Želvienė, Aušra. "Women beliefs towards breast cancer, breast self-examination and mammography in connection with participation in breast cancer screening." Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2008. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2008~D_20080129_121108-78281.

Повний текст джерела
Анотація:
The aim of the study is to assess the connection between women’s participation in breast cancer screening and beliefs towards breast cancer, breast self-examination and mammography. The objectives of the study: 1. To assess validity and reliability of Champion Health Belief Model Scale for beliefs towards breast cancer, breast self-examination and mammography screening for Lithuanian women. 2. To estimate perceived susceptibility, perceived severity, perceived benefits, perceived barriers, confidence and health motivation. 3. To compare beliefs towards breast cancer, breast self-examination and mammography screening of participant and non-participant women in the screening program. 4. To assess perceived barriers towards mammography screening. 5. To investigate the role of information about breast cancer and mammography screening for women‘s beliefs towards breast cancer, breast self-examination and mammography screening. CONCLUSIONS 1. Champion Health Belief Model Scale is a valid and reliable to assess beliefs towards breast cancer, breast self- examination and mammography. The barriers- mammography item “Regular mammography screening would make me worry about breast cancer” was inappropriate to the scale and expunged from the questionnaire. 2. Surveyed women did not feel much threat to get breast cancer. They overvalued benefits of breast self-examination and positively rated mammography screening. However, confidence to perform breast self-examination was properly low... [to full text]
Šio darbo tikslas buvo įvertinti atvykusių ir neatvykusių tikrintis mamografiškai moterų nuostatų į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą skirtumus. Tikslui pasiekti iškelti tokie uždaviniai: 1. Įvertinti Champion VL sveikatos įsitikinimų modelio klausimyno tinkamumą tirti Lietuvos moterų nuostatoms į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą. 2. Nustatyti moterų suvoktą krūties vėžio grėsmę, apsaugančios nuo krūties vėžio pasekmių elgsenos naudą ir kliūtis šiai veiklai, sveikos gyvensenos motyvaciją. 3. Palyginti atvykusių ir neatvykusių tirtis mamografiškai dėl krūties vėžio moterų nuostatas į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą. 4. Įvertinti dalyvavusių atrankinėje mamografinėje patikroje dėl krūties vėžio moterų kliūtis tirtis mamografiškai. 5. Ištirti papildomos informacijos apie krūties vėžį, mamografinę patikrą įtaką moterų nuostatoms į krūties vėžį, savityrą bei atrankinę mamografinę patikrą ir moterų dalyvavimui atrankinės patikros programoje. Išvados: 1. Patikrintas ir įteisintas VL Champion sveikatos įsitikinimų modelio skalės klausimynas yra tinkamas Lietuvos moterų nuostatoms į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą tirti. Sveikos gyvensenos motyvacijos skalė turi būti padalinta į požiūrio į sveiką gyvenseną ir veiklos sveikatos labui subskales. Kliūčių tirtis mamografiškai teiginys “reguliarus mamografinis ištyrimas verstų mane nerimauti dėl krūties vėžio” išbrauktas... [toliau žr. visą tekstą]
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Puig, Vives Montserrat. "Breast cancer epidemiology: mammographic screening and molecular subtypes." Doctoral thesis, Universitat de Girona, 2015. http://hdl.handle.net/10803/289426.

Повний текст джерела
Анотація:
The aim of this thesis is to carry out an in-depth study of various aspects of breast cancer epidemiology. Firstly, we have confirmed that DCIS incidence in Girona has increased over recent decades. Proportions of screen-detected cancers, interval cancers and non-screen-detected cancers during the start-up phase of the mammographic screening programme were found to be 42.2%, 5.8% and 52.2%, respectively. Secondly, we have found that luminal A-like was the most frequent subtype associated with the best survival rate, while triple-negative breast cancer was related to the lowest survival rate. Importantly, we have concluded that breast cancer molecular subtype defined by IHC biomarkers provides prognostic value, regardless of age, tumour size, histological grade, lymph node involvement and method of detection. Finally, we have demonstrated that method of detection also provides prognostic value regardless of age, tumour size, histological grade, lymph node involvement and breast cancer molecular subtype defined by IHC biomarkers.
L’objectiu d’aquesta tesi és realitzar aprofundir en diversos aspectes de l'epidemiologia del càncer de mama. Hem confirmat que la incidència del DCIS a Girona ha augmentat en les últimes dècades. Les proporcions dels càncers detectats mitjançant el programa de cribratge, fora d’aquest i els càncers d'interval van ser del 42,2%, 52,2% i 5,8%, respectivament. Per altra banda, el subtipus amb la supervivència més elevada i més baixa van ser el luminal A-like i el triple negatiu, respectivament. És important destacar que el subtipus molecular de càncer de mama definit per biomarcadors determinats amb tècniques d’IHC proporciona valor pronòstic, independentment de l'edat, la mida, el grau histològic, l’afectació dels ganglis i el mètode de detecció. Finalment, hem demostrat que el mètode de detecció del càncer també proporciona valor pronòstic independentment de l'edat, la mida, el grau histològic, l'afectació dels ganglis i el subtipus molecular.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Iliouchina, Natalia V. (Natalia Vladimirovna) 1979. "Models for the effectiveness of breast cancer screening." Thesis, Massachusetts Institute of Technology, 2001. http://hdl.handle.net/1721.1/86804.

Повний текст джерела
Анотація:
Thesis (M.Eng. and S.B.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2001.
Includes bibliographical references (leaf 72).
by Natalia V. Iliouchina.
M.Eng.and S.B.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Hammond, Marsha V. "Breast Cancer Screening Health Behaviors in Older Women." Thesis, University of North Texas, 1994. https://digital.library.unt.edu/ark:/67531/metadc278973/.

Повний текст джерела
Анотація:
Health beliefs of 221 postmenopausal women were assessed to predict the Breast Cancer Screening Behaviors of breast self-examination (BSE) and utilization of mammography. Champion's (1991) revised Health Belief Model (HBM) instrument for BSE, which assesses the HBM constructs of Seriousness, Susceptibility, Benefits, Barriers, Confidence and Health Motivation, was utilized along with her Barriers and Benefits instrument for mammography usage. Ronis' and Harel's (1989) constructs of Severity-Late and Severity-Early were evaluated along with Cuing and demographic variables. These exogenous latent constructs were utilized in a LISREL path model to predict Breast Cancer Screening Behavior.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Goldzahl, Léontine. "A behavioral approach to breast cancer screening decision." Thesis, Paris 1, 2015. http://www.theses.fr/2015PA010011.

Повний текст джерела
Анотація:
Cette thèse étudie les facteurs d’offre et de demande associés au recours au dépistage du cancer du sein. Parmi les facteurs d’offre, j’examine comment la coexistence du dépistage organisé au côté du dépistage individuel influence le contenu de l’examen de dépistage ainsi que le recours régulier au dépistage. En plus des facteurs de demande tels les caractéristiques socioéconomiques, une attention particulière est portée à la possibilité d’expliquer le recours régulier au dépistage par les préférences face au risque et temporelles ainsi que les perceptions. À partir de régularités psychologiques identifiées dans les travaux d’économie comportementale et de psychologie, trois interventions de type nudge sont testées dans le cadre d’une expérience randomisée sur le terrain visant à augmenter le taux de dépistage dans le programme national
This thesis explores supply and demand factors associated with the use of breast cancer screening. Among the supply factors, I examine how the coexistence of organized and opportunistic screenings influences the content of the screening exam and screening regularity. Besides the usual demand factors such as socioeconomic characteristics, a special attention is being given to the possibility of explaining screening regularly by individuals’ risk and time preferences and perceptions. Based on psychological patterns identified in the literature in behavioral economics and psychology, three nudge interventions are tested in a randomized field experiment to increase the national program uptake rate
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Patino, Patricia. "Breast cancer : relationship betweern acculturation and barriers to breast cancer screening in Southwest Florida Latinas." [Tampa, Fla] : University of South Florida, 2006. http://purl.fcla.edu/usf/dc/et/SFE0001867.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Screening of Breast Cancer"

1

MRCGP, Humphreys John, Cancer Research Campaign (Great Britain), and National Breast Screening Programme (Great Britain), eds. Breast cancer screening. Oxford: Oxford University Press, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Screening for breast cancer. London: Faculty of Community Medicine of the Royal Colleges of Physicians of the United Kingdom, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Screening for breast cancer. London: The Colleges, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

E, Day N., and Miller A. B, eds. Screening for breast cancer. Toronto: Huber, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Elizabeth, Parvin, ed. Screening for breast cancer. Oxford: Oxford University Press, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

E, Day N., Miller, A. B. (Ed.), and International Union Against Cancer, eds. Screening for breast cancer. Bern: Hans Huber, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Farrow, Alexandra. Breast cancer screening thesaurus. Bristol: Health Care Evaluation Unit, Department of Epidemiology and Public Health Medicine, University of Bristol, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Gad, Adel, and Marco Rosselli Del Turco, eds. Breast Cancer Screening in Europe. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78154-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Shetty, Mahesh K., ed. Breast Cancer Screening and Diagnosis. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1267-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Breast cancer screening and prevention. Hauppauge, N.Y: Nova Science, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Screening of Breast Cancer"

1

Moss, S. M. "Breast Cancer." In Cancer Screening, 143–70. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429179587-10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Selvi, Radhakrishna. "Breast Cancer Screening." In Breast Diseases, 15–19. New Delhi: Springer India, 2014. http://dx.doi.org/10.1007/978-81-322-2077-0_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

von Fournier, D., H. W. Anton, H. Junkermann, and G. Bastert. "Breast Cancer Screening." In Cancer Diagnosis, 78–87. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76899-6_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Chamberlain, J. "Screening for Breast Cancer." In Breast Cancer, 45–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83675-6_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Nelson, Heidi D. "Breast Cancer Screening." In Cancer and Aging Handbook, 125–38. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118312513.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Miller, Anthony B. "Breast Cancer Screening." In Epidemiologic Studies in Cancer Prevention and Screening, 263–76. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5586-8_17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Rockoff, Steven, and Joseph D. Calandra. "Breast Cancer Screening." In Ambulatory Gynecology, 1–20. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7641-6_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Jatoi, Ismail. "Breast Cancer Screening." In Management of Breast Diseases, 131–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-69743-5_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Kerlikowske, Karla. "Breast Cancer Screening." In Breast Cancer Epidemiology, 343–69. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0685-4_16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Kirsh, Susan, and Anita Misra-Hebert. "Breast Cancer Screening." In Encyclopedia of Immigrant Health, 318–20. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_100.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Screening of Breast Cancer"

1

Couto, Henrique Lia, Nayara Carvalho de Sá, Rachel Saraiva Teatini Selim de Sales, Tereza Cristina Ferreira de Oliveira, Patrícia Martins Gomes El Bacha, Shirley das Graças Ferreira, Gabriel de Almeida Silva Junior, and Carolina Nazareth Valadares. "SUCCESSFUL RECOVERY OF BREAST CANCER SCREENING AND DIAGNOSIS RATES DURING COVID-19 PANDEMIC BY ADOPTING THE RECOMMENDATIONS OF THE BRAZILIAN COLLEGE OF RADIOLOGISTS (CBR), THE BRAZILIAN FEDERATION OF GYNECOLOGISTS AND OBSTETRICIANS (FEBRASGO), AND THE BRAZILIAN MASTOLOGY SOCIETY (SBM): DATA FROM A PRIVATE BREAST UNIT IN BELO HORIZONTE, BRAZIL." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2100.

Повний текст джерела
Анотація:
Objectives: To present the results of adopting CBR/FEBRASGO/SBM recommendations for breast cancer screening and diagnosis during 2020 COVID-19 PANDEMIC on mammograms (MMG), breast ultrasound (BUS), breast biopsy (BB), and cancer diagnosis (CD) rates. Methodology: Comparing by month the total number of MMG, BUS, BB (composed of fine needle, core, and vacuum procedures), and invasive and in situ cancers diagnosis (CD) performed at Redimama, a private breast unit from Belo Horizonte Brazil, that adopted CBR/FEBRASGO/SBM recommendations for breast cancer screening and diagnosis during the 2020 COVID-19 pandemic year to 2019 same period. Results: In April 2019, 391 MMG, 714 BUS, 223 BB, and 22 CD were performed, compared with 115 (29.4%) MMG, 313 (43.8%) BUS, 116 (52%) BB, and 11 (50%) CD in 2020. A continuous and fast recovery occurred along the time. In 2019 first semester, 2241 MMG, 4229 BUS, 1214 BB, and 84 CD were performed, compared with 1,903 (88.7%) MMG, 4,227 (99.2%) BUS, 1,044 (86%) BB, and 92 (109.5%) DC in 2020. In 2019, 4,424 MMG, 10,395 BUS, 3,304 BB, and 231 CD were performed, compared with 4,561 (110.79%) MMG, 11,549 (120.72%) BUS, 3,011 (91.13%) BB, and 226 (97.83%) CD in 2020. In 2019, the median size in image (T) by MMG/BUS for invasive cancers (IC) was 18.18 mm, from CD 184 (79.66%) were IC, and 47 (20.4%) ductal carcinoma in situ (DCIS) compared to a T of 18.2 mm, 191 (86.52%) IC, and 35 DCIS in 2020. Conclusion: Adopting the CBR/FEBRASGO/SBM recommendations for breast cancer screening and diagnosis results to recovery the prior pandemic levels. Recovery of MMG and BUS is faster and shows a “J” curve compared with recovery of BB and CD that shows a “´U”` curve with a delay. This strategy should be adopted in Brazil in order to maintain breast cancer screening and diagnosis.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Boone, John M. "Dedicated Breast CT for Breast Cancer Screening." In MEDICAL PHYSICS: Seventh Mexican Symposium on Medical Physics. AIP, 2003. http://dx.doi.org/10.1063/1.1615091.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Sfakianakis, Eleftherios, Foivos Irakleidis, Katerina Ntailian, and Peng Tan. "CLINICAL SIGNIFICANCE OF BREAST DENSITY: IS THERE ANY NEED FOR SUPPLEMENTAL SCREENING?" In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2006.

Повний текст джерела
Анотація:
Objectives: Mammographic density (MD) is the amount of fibroglandular breast tissue, which appears relatively radiopaque on mammography when compared with fat that appears radiolucent. It may obscure an underlying breast cancer (BC), thus decreases mammographic sensitivity. MD is also an independent BC risk factor. MD is most commonly classified by the Breast Imaging Reporting and Data System (BI-RADS), fifth edition, 2012, where breast density is determined by radiologists using visual assessment that is subject to inter-rater variability. The term “dense breasts” refers to either heterogeneously dense or extremely dense breasts (category C or D), accounting for approximately 47%–50% of women. Supplemental screening modalities, such as digital breast tomosynthesis (DBT), MRI, and ultrasound, when combined with digital mammography (DM) have shown to be effective in the identification of mammographically occult breast lesions in high breast density patients. In this study, we examined the potential value of available screening modalities and their importance in patients with increased MD. Methodology: We conducted a systematic review of the literature via MEDLINE assessing the clinical importance of MD and its role in supplemental screening protocols. Results: Reduced mammographic sensitivity — Mammographic sensitivity rate is adversely proportional to MD. Breast stromal component and hence stromal stiffening promote an increase in MD. Another important factor is that extracellular matrix stiffness has been found to be tumorigenic and is significantly associated with BC. As a consequence, the combined relative BC risk is increased exponentially in levels A, B, C, and D BI-RADS categories, respectively. Supplemental screening modalities — To overcome the limitations of digital mammography in higher MD categories, the introduction of DBT has significantly improved BC detection and reduced recall rates when added to mammography. Both STORM-1 and STORM-2 trials showed the significant improvement in BC detection rate when DBT was combined with DM. On the other hand, MBTST trial revealed an increase of false-positive rates when BC screening was carried out with DBT alone. In another multicenter study, the ACRIN Protocol 6666 established that the addition of ultrasound (US) to DM in women within BI-RADS C and D groups will identify an additional 1.1–7.2 cancers per 1,000 high-risk women, but substantially increase the number of false positive results. Breast MRI may be offered as supplemental screening modality in women with heterogeneous or extremely dense breast tissue. The combination of MRI with DM and US in screening of heterogeneous or extremely dense breasts with at least one risk factor for BC produces a 100% sensitivity rate. Also, supplemental MRI screening in women with extremely dense breasts can reduce the incidence of undetected interval BC. On the contrary, the addition of MRI possesses low specificity rates and increased cost. Conclusions: Increased BD is a common mammographic finding in women. Although very common, its association with reduced mammographic sensitivity and consequently BC detection masking is of high clinical significance. Additionally, BD alone is a risk factor for BC, despite the fact that the exact mechanisms of tumorigenesis associated to it are yet to be fully understood. Supplemental screening modalities, such as DBT, MRI, and US, when combined with DM have been shown to be effective in the identification of mammographically occult BC in high BD patients. The increased number of unnecessary biopsies as a result of increased false positivity rates may increase the physical and psychological patient burden. Since there is no consensus for routine use of DBT or MRI in screening of women with increased BD, the decision for supplemental screening should be personalized.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Souza, Letícia Passos, Sabrina Santos Alves, and Ícaro García Viana. "BRAZILIAN OUTLOOK OF BREAST CANCER MORTALITY IN VALIDITY OF MAMMOGRAPHIC SCREENING - A TIME REVIEW." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1044.

Повний текст джерела
Анотація:
Introduction: Breast Cancer is the cancer with the highest incidence among the female population at national and worldwide levels, except for non-melanoma skin cancer. It is also the main cause of cancer deaths in women, representing an important public health problem. This scenario justifies the implementation of strategies that aim to reduce mortality and morbidity rates in its target population. Based on this demand, the document “Breast Cancer Control - Consensus Document” was prepared in 2004 by the Brazilian National Cancer Institute (INCA) and the Brazilian Department of Health, with an improvement in 2015 through the “Guidelines for Early Detection of Breast Cancer in Brazil”. Objectives: The objective of the present work is to evaluate the outlook of breast cancer mortality in women in Brazil between the years 2009 and 2018, considering the mammographic screening implementation. Methods: A retrospective and descriptive epidemiological study was carried out using the last ten years of Brazilian data available on INCA’s Online Mortality Atlas (from 2009 to 2018). In addition, documents released by INCA and the Department of Health that contemplate breast cancer issues in women and mammographic screening were selected, as they reflect the reality of the country. The age group primarily observed was between 50 and 69 years, which correspond to that indicated for mammographic screening in the current legislation. Results: Deaths due to breast cancer rose from 11,968 to 17,572 between 2009 and 2018, which represents an increase of 46.82%, as shown in Table 1. Considering the same time frame, the values in percentage show an increase of 0.48% when compared to the total number of deaths (from 2.54% to 3.02% - as shown in Table 2). The mortality rate by age group increased: from 32.54 to 35.63 for the group aged 50 to 59 and from 41.78 to 53.63 for the group aged 60 to 69 years. The data show the persistent increase in the mortality rate due to the disease, despite the implementation of mammographic screening. The significant reduction in mortality predicted in the literature for the age group 50 to 69 years depends on factors such as high coverage and quality of screening, in addition to adequate treatment. Globalization and industrialization increased exposure to risk factors. The increase in life expectancy is expected to interfere with incidence and prevalence. Conclusions: Conditions mentioned above may justify the increase in mortality. Therefore, the relevance of screening in cancer’s pre-clinical identification still justifies its indication and implantation.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Rocha, Aline Ferreira Bandeira de Melo, Ruffo de Freitas Júnior, Rosemar Macedo Sousa Rahal, Danielle Cristina Cristina Netto Rodrigues, Rosangela da Silveira Corrêa, Glalber Luiz da Rocha Ferreira, and Edésio Martins. "MAMMOGRAPHIC SCREENING COVERAGE IN ELDERLY WOMEN IN BRAZIL." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2055.

Повний текст джерела
Анотація:
Objective: The aim of this study was to assess trends in breast cancer screening in the Unified Health System (SUS) in women over 70 years of age, during 2010–2021, and to assess the frequency of malignant lesions in this group, from 2014 to 2021. Methods: This is an ecological study on breast cancer screening in elderly women in the SUS in Brazil from 2010 to 2021. Data were extracted from the Outpatient Information System of the SUS Informatics Department and the Cancer Information System. Coverage was calculated from the ratio between the number of mammograms performed and the number expected for the population at risk. Results: We observed that in Brazil there was an average mammographic coverage of 6.7% in this age group. The south region had the highest coverage with an average of 8.9% for the period, while the north region had the lowest rate of 3.1%. Among the states, São Paulo and Paraná, with 9.9% and 9.6% respectively, had the highest rates. There was a reduction in the coverage rate in the analyzed period, more pronounced in 2020–2021 due to the COVID-19 pandemic, caused by the reduction in the active demand of women for health treatment in this context. The number of examinations with a diagnosis of the malignant lesion followed a pattern and increased until 2019, followed by a decrease in 2020, due to COVID-19 and an increasing trend in 2021. The total number of examinations in the analyzed period was 13,090, an increase of 1,604% compared to 2014. The states that showed most participation in these results were São Paulo (16%), Minas Gerais (16%), Paraná (14%), and Pernambuco (13%). Conclusion: The number of breast cancer cases in elderly women has increased, but screening has not followed this trend. It is necessary to rethink the assistance to this age group, discussing public health measures that address this reality.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Pereira, Lucas F. S., Sarah B. D. Carrijo, Larissa F. Almeida, Jordana M. Oliveira, Beatriz de A. Negraes, Cesar A. S. T. Vilanova Costa, and Antonio M. T. C. Silva. "MAMMOGRAPHY AND BREAST CANCER: ANALYSIS OF A PROVEN SCREENING METHOD." In Brazilian Breast Cancer Symposium. v29s1, 2019. http://dx.doi.org/10.29289/259453942019v29s1ep52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Moreno, Andre, Kimberly Masiero Cola, Larissa Heberle, and Marcelo Moreno. "RELATIONSHIP BETWEEN IMMUNOHISTOCHEMICAL CHARACTERIZATION AND FORM OF DIAGNOSIS OF BREAST CANCER." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1008.

Повний текст джерела
Анотація:
Introduction: Breast cancer is the most incident neoplasia among Brazilian women. According to immunogenetic characteristics, it is possible to verify that malignant breast neoplasms with greater biological activity would be those classified as luminary B, HER2+ and triple-negative, and that the one with the lowest biological activity would be the luminal subtype A. Thus, a mammography would be more likely to detect cancers with a low degree of biological characteristics such as “luminal A”. On the other hand, mammary carcinomas with greater potential for systemic dissemination show faster growth in the breast parenchyma and are detected predominantly by self-examination. Knowledge of this difference in the clinical behavior of mammary malignant neoplasms is important for the diagnosis of “interval” breast cancers, that is, breast cancer that appears in the period between the performance of annual screening mammograms. Objectives: Verify the relationship between immunohistochemical characterization of malignant breast neoplasms and the finding that motivated the medical consultation, in women with breast cancer and residents of Western Santa Catarina, Brazil. Methods: Observational, cross-sectional study, which included women diagnosed with breast cancer and treated at an oncology referral center in the city of Chapecó, state of Santa Catarina, Brazil, from January 2000 to December 2016. Patients that presented medical records whose main complaint was towards the diagnosis of breast cancer were included (example: nodule diagnosed by imaging exams, self-examination, clinical examination). Besides this, the breast injury related to this complaint should have been breast cancer diagnosed by an anatomopathological examination and an immunohistochemistry study. The project was developed in accordance to CEP/UNOCHAPECO no. 1819869. Results: Data from 209 patients were analyzed, from which 83 (39.7%) cases of breast cancer were detected by a mammography examination; 115 (55%) cases by breast self-examination and 11 (5.2%) cases by other forms of examination, which included clinical breast examination done by a doctor, magnetic resonance imaging and ultrasound. The luminal A immunohistochemical profile was more prevalent among patients who underwent breast cancer detection through mammography (62.6%). There was a correlation between lymph node invasion and the screening method, in which 78.6% of cancers detected by self-examination showed expansion to lymph nodes, while those detected by mammography presented an invasion rate of 45.7% (p=0.002). Conclusions: Breast cancer with immunohistochemical characterization, related to greater biological activity, were most often detected by self-examination, while neoplasms with indolent development were diagnosed predominantly by mammography.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Novaes, Danyelle Santos, João Paulo Medrado Santos, Camille Teles Ferreira de Almeida, Dandara Rocha Ramos, and Manuela Santana Aguiar. "THE IMPACT OF THE COVID-19 PANDEMIC ON THE PERFORMANCE OF MAMMOGRAPHIES IN THE BRAZILIAN NORTHEAST: AN ECOLOGICAL STUDY." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2023.

Повний текст джерела
Анотація:
Objective: The aim of this study was to evaluate breast cancer screening according to demographic data, year of completion, age group, and geographic distribution in the pandemic period. Methods: An ecological study was carried out using data collected by the Departamento de Informática do Sistema Único de Saúde (DATASUS). The study population included patients who underwent screening for breast cancer in northeastern Brazil between 2019 and 2021. Results: The National Cancer Institute recommends biannual breast cancer screening through mammography for women aged 50–69 years. However, in 2020, the COVID-19 pandemic generated consequences such as the withdrawal of patients from health services, interfering with the performance of preventive mammography. In northeastern Brazil, 879,903 mammograms were performed on female patients in 2019, a number that was reduced by 39.23% in 2020 (534,647) and 5.68% in 2021 (829,902). A drop was also found in the number of examinations per target audience, especially in the year 2020 (40.36%) when compared to the year 2019, with the age group 50–54 years having the largest reduction, with a drop of 40.05%. It was found that between 2019 and 2020, all northeastern states had a drop in the number of examinations performed, with the largest drop being in Sergipe (52.54%). Despite this, in 2021, some states showed an increase in the number of examinations performed when compared to 2019, with Piauí standing out (50.54%). Conclusion: In the COVID-19 pandemic, there was a decrease in breast cancer screening between the years 2019 and 2020 in northeastern Brazil, with a discrete rise in the number of examinations performed in some states in 2021. The youngest age group of the target audience was the most negatively impacted. Thus, the need to use these data to formulate public policies to encourage screening and reduce morbidity and mortality from breast cancer is evident.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Demigha, Souad. "Data mining for breast cancer screening." In 2015 10th International Conference on Computer Science & Education (ICCSE). IEEE, 2015. http://dx.doi.org/10.1109/iccse.2015.7250219.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Cruz, Alexandra La, Carlos Andres Diaz Santacruz, Leisson Polo, and Erika Severeyn. "Breast Cancer Screening Using Deep Learning." In 2022 IEEE Sixth Ecuador Technical Chapters Meeting (ETCM). IEEE, 2022. http://dx.doi.org/10.1109/etcm56276.2022.9935747.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Screening of Breast Cancer"

1

Greenberg, Robert, and Patricia Carney. Regional Breast Cancer Screening Network. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada394136.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Alfano, Robert R. Breast Cancer Screening Using Photonic Technology. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada399367.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Boone, John M. Computer Simulation of Breast Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, July 1999. http://dx.doi.org/10.21236/ada383107.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Alfano, Robert R. Breast Cancer Screening Using Photonic Technology. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada384638.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Workman, Sarah, and Maddy Thompson. Breaking down barriers: Empowering Black women in breast cancer care. Royal Geographical Society (with IBG), March 2022. http://dx.doi.org/10.55203/vvdj9112.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada395007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada406787.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2004. http://dx.doi.org/10.21236/ada426440.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada418130.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Fort, Jane G., and Nasar U. Ahmed. Empowering Factors Among Breast Cancer Screening Compliant Underserved Populations. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada443597.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Screening of Breast Cancer" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії